Fast, convenient, cheap, accurate, and widely-used COVID-19 tests can help identify both infected individuals who should self-isolate and those who have recovered, pose low contagion risks, and can help others fight the virus.

This brief identifies five key payer functions likely to be affected by the COVID-19 pandemic and actions payers can take to ensure business continuity while enhancing their contributions to the value chain.

In the wake of the COVID-19 pandemic, could telehealth have the potential to replace some in-person services and better triage care based on needs?

The onset of COVID-19 and the impact on capital markets pose several challenges for Indian life insurers.

This paper summarises the three main delays that EIOPA recommends regulators offer to provide operational relief to undertakings if so needed during the COVID-19 pandemic.

How should actuaries think and spend their time in regard to the COVID-19 pandemic?

This article examines early mortality experience related to COVID-19 and includes a discussion about the difficulties in using this data.

The COVID-19 pandemic is raising some profound questions for risk practitioners.

This paper discusses actuarial perspectives for the calculation of the capital requirement related to catastrophic pandemic mortality as required by the Solvency II regulation.

Healthcare providers, facilities, and MPL writers can expect direct and indirect impacts from the coronavirus pandemic—with the indirect impact possibly proving more impactful over the long term.

With the unprecedented challenges presented by the current and future effects of COVID-19, management and directors will need to be cautious with their decisions and consider consequences not presented in prior difficult times.

Firms need to be thinking and acting with dynamism to manage the here and now of the coronavirus pandemic and plan effectively for multiple future scenario pathways.

This article further explores the coronavirus under the lens of a set of key principles we believe are fundamental to effective emerging risk analysis.

With the addition of the global COVID-19 pandemic, an already tumultuous D&O insurance environment has the potential to get much worse.

This article focuses on the CARES Act provision allowing deferment to January 1, 2021, of required defined benefit contributions due in the 2020 calendar year.

This alert describes Title III (Supporting America’s Health Care System in the Fight Against the Coronavirus), Part II (Access to Healthcare for COVID-19 Patients), Subpart A (Coverage of Testing and Preventive Services), of the CARES Act, which expands upon Division F, Health Provisions, of the Families First Coronavirus Response Act.

The turmoil the COVID-19 pandemic has caused in financial markets raises profound and potentially long-lasting concerns for pension plan sponsors.

While many non-essential businesses are closing temporarily due to government requirements, even leading to staff layoffs in some cases, essential employers in some regions are experiencing the need to increase staffing levels.

As employers are facing the harsh reality of implementing layoffs to maintain economic viability, there may be unintended consequences to various retirement programs, especially pension, post-retirement benefit, and other plans.

These FAQs help you thoughtfully consider the potential effects that market volatility resulting from COVID-19 can have on your plan.

This article contains specific information about what the “Families First Coronavirus Response Act” covers.

The 1,190.95-point Dow decline on February 27, 2020, is the largest we’ve seen in the history of the Dow and amounts to a drop of over 4.4%.